Hypoglycemia remains the greatest barrier to achieving and maintaining tight glycemic control in people with type 1 diabetes and people with type 2 diabetes on insulin therapy or sulfonylurea treatment [5]. This evidence concerns the gene INS and type 1 diabetes mellitus.